周 玥,張文會,劉雄利,周 英,余章彪
(貴州大學 藥學院,貴州 貴陽 550025)
多官能團氧化吲哚廣泛存在天然產(chǎn)物和合成藥物分子中,其中,尤其3-季碳氧化吲哚因為具有廣泛的生物活性,吸引了許多化學工作者及醫(yī)藥化學團隊的廣泛關(guān)注[1,2]。研究表明,在保留天然藥物活性骨架結(jié)構(gòu)基礎(chǔ)上,通過方法學合成的3-季碳烷基氧化吲哚類化合物,同樣具有很好的生物活性[5,6]。因此通過新方法合成更多類型的3-季碳烷基氧化吲哚,可以為吲哚類化合物在藥物發(fā)現(xiàn)和成藥性評價中的應(yīng)用建立物質(zhì)基礎(chǔ),具有重要的研究意義。
為了滿足活性篩選和新藥研究開發(fā)的需要,我們按圖 1所示合成路線,以3-單取代的氧化吲哚1為起始原料,用DMF做溶劑,在堿性氫化鈉和室溫條件下,通過和鹵代烷R2X反應(yīng),區(qū)域選擇性得到3-季碳烷基氧化吲哚(2a~2f),結(jié)構(gòu)經(jīng)1H NMR,13C NMR和HR MS表征。
Bruker-400 MHz 型核磁共振儀(CD3Cl為溶劑,TMS為內(nèi)標); Bruker BIO TOF III Q 型質(zhì)譜儀。所用試劑均為分析純;所用無水溶劑均按標準程序進行脫水處理。
2a為例:
稱取315 mg 3-對溴芐基氧化吲哚1a (1 mmol)溶解在10 mL的DMF中,加入44 mg催化劑NaH(1.1 eq, 60%含量),室溫攪拌10分鐘后,加入213 mg碘甲烷 (1.5 eq), 繼續(xù)室溫攪拌1 h,加入水萃滅反應(yīng),乙酸乙酯萃取,硫酸鎂干燥,減壓除掉溶劑,殘余物經(jīng)硅膠柱層析 [洗脫劑:V(乙酸乙酯)∶V(石油醚) = 1∶10],分離得到299.4 mg白色物質(zhì)2a, 產(chǎn)率91%。
圖1 區(qū)域選擇性合成3-季碳烷基氧化吲哚Fig.1 Regioselective synthesis of 3-quaternary alkyl oxindoles
相應(yīng)反應(yīng)底物按同樣計量比投量,按合成2a的類似方法,分別合成2b~2e.
2a:白色固體,299.4 mg,總收率91%。1H NMR(500 MHz,CDCl3)δ:7.12-7.06(m,4H),6.98-6.95(m,1H),6.62(d,J=8.7 Hz,2 H),6.55(d,J=7.8 Hz,1H),3.01(d,J=13.1 Hz,1H),2.91(s,3H),2.87(d,J=13.1 Hz,1H),1.38(s,3H);13C NMR(CDCl3,125 MHz)δ:179.5,143.0,135.1,132.5,131.4,130.5,127.9,123.0,122.1,120.4,107.9,49.7,43.7,25.8,22.8;HRMS(ESI-TOF)m/z:Calcd.forC17H16BrNNaO[M+Na]+:352.0313;Found:352.0315.
3b:白色固體,352.4 mg,總收率87%。1H NMR(500 MHz,CDCl3)δ:7.16-7.11(m,3H),7.08-6.98(m,5H),6.88-6.86(m,2H),6.74-6.72(m,2H),6.36(d,J=7.7 Hz,1H),3.27(dd,J=13.1,3.3Hz,2H),3.09(dd,J=24.8,13.1 Hz,2H),2.74(s,3H);13C NMR(CDCl3,125 MHz)δ:180.0,143.5,135.6,135.0,131.6,130.6,129.9,129.6,127.9,127.5,126.4,124.0,121.7,120.4,107.7,55.9,43.4,42.4,25.6;HRMS(ESI-TOF)m/z:Calcd.forC23H20BrNNaO[M+Na]+:428.0626;Found:428.0627.
3c:白色固體,238.6 mg,總收率90%。1H NMR(500 MHz,CDCl3)δ:7.12-7.01(m,1H),7.04-7.02(m,1H),6.97-6.93(m,1H),6.88-6.85(m,1H),6.81(d,J=7.6 Hz,1H),6.59-6.54(m,3H),2.98(d,J=13.0 Hz,1H),2.93(s,3H),2.90(d,J=13.0 Hz,1H),2.09(s,3H),1.39(s,3H);13C NMR(CDCl3,125 MHz)δ:183.0,146.1,139.4,139.1,136.1,133.6,130.7,130.3,130.1,129.9,126.4,124.9,110.7,52.8,47.4,28.9,25.6,24.2;H RMS(ESI-TOF)m/z:Calcd.forC18H19NNaO[M+Na]+:288.1364;Found:288.1365.
3d:白色固體,303.7 mg,總收率89%。1H NMR(500 MHz,CDCl3)δ:7.06(d,J=7.3 Hz,1H),7.01-6.90(m,5H),6.87-6.78(m,4H),6.62(d,J=12.0 Hz,2H),6.30(d,J=7.7 Hz,1H),3.20(dd,J=26.0,13.1Hz,2H),3.05(dd,J=13.0,8.8 Hz,2H),2.69(s,3H),2.07(s,3H);13C NMR(CDCl3,125 MHz)δ:178.5,143.6,137.0,136.0,135.9,130.8,130.2,130.0,127.7,127.5,127.3,127.0,126.3,124.4,121.5,107.5,56.0,43.2,25.6,21.2;HRMS(ESI-TOF)m/z:Calcd.forC24H23NNaO[M+Na]+:364.1677;Found:364.1677.
3e:白色固體,258.6 mg,總收率92%。1H NMR(500 MHz,CDCl3)δ:7.12-7.09(m,1H),7.06-7.04(m,1H),6.97-6.94(m,1H),6.69-6.67(m,2H),6.55(d,J=7.8 Hz,1H),6.52-6.50(m,2H),3.61(s,3H),2.98(d,J=13.2 Hz,1H),2.92(s,3H),2.88(d,J=13.2 Hz,1H),1.37(s,3H);13C NMR(CDCl3,125 MHz)δ:180.0,158.1,143.1,133.1,130.7,128.3,127.7,123.2,122.0,112.8,107.8,55.0,50.0,43.6,25.9,22.6;HRMS(ESI-TOF)m/z:Calcd.forC18H19NNaO2[M+Na]+:304.1313;Found:304.1317.
在合成3-季碳烷基氧化吲哚(2a~2f)時,需用過量的NaH (1.1eq),否則會影響收率。鹵代烷對反應(yīng)速度和產(chǎn)率有一定影響,碘甲烷的反應(yīng)速率高于芐溴的反應(yīng)速率,產(chǎn)率也較高。這可能是碘甲烷的活性要高,增強其親電性,從而提高了反應(yīng)產(chǎn)率。
圖2 可能的反應(yīng)機理Fig.2 Plausible mechanism for the reaction
合成3-季碳烷基氧化吲哚(2a~2f)的反應(yīng)機理如圖2 所示。從實驗結(jié)果推測出,3-單取代氧化吲哚1在堿性NaH的作用下,變成烯醇式,再失去氫原子變成氧負離子,氧負離子并沒有直接作為給體與親電子的受體鹵代烷發(fā)生SN2反應(yīng),而是區(qū)域選擇性地繼續(xù)發(fā)生烯醇互變成酮式結(jié)構(gòu),使氧化吲哚的3位作為給體與與親電子的受體鹵代烷發(fā)生SN2反應(yīng),最終生產(chǎn)產(chǎn)物3-季碳烷基氧化吲哚(2a~2f)。
本文以3-單取代的氧化吲哚1為起始原料,用DMF做溶劑,在堿性氫化鈉和室溫條件下,通過和鹵代烷R2X反應(yīng),得到3-季碳烷基氧化吲哚(2a~2f),產(chǎn)率為87~92%,結(jié)構(gòu)經(jīng)1H NMR,13C NMR和HR MS表征。討論了底物取代基對反應(yīng)產(chǎn)率的影響, 探討了區(qū)域選擇性的反應(yīng)機理, 為3-季碳烷基氧化吲哚在藥物發(fā)現(xiàn)和成藥性評價中的應(yīng)用建立物質(zhì)基礎(chǔ)。
[1] Venkata Jaganmohan Reddy, Christopher J.Douglas.Catalytic C-CN activation and asymmetriccyanoamidation of alkenes: total syntheses of (+)-horsfiline, (-)-coerulescine, and (-)-esermethole [J].Tetrahedron, 2010(66): 4719-4729.
[2] Munawar Hussaina, Serge-Mitherand Tengho Toguem, Peter Langer,etal.Synthesis of carbazoles and 1,2-dihydrocarbazoles by domino‘twofold Heck/6p-electrocyclization’ reactions of di-, tri- and tetrabromoindoles [J].Tetrahedron, 2011(67): 5304-5318.
[3] 劉雄偉, 周 根, 姚 震, 等.異噁唑拼接吡咯螺環(huán)氧化吲哚化合物的合成及起抗腫瘤活性[J]. 合成化學, 2016, 24(5): 22-31.
[4] Liu X L, Yuan W C.A simple and eco-friendly method for the aminomethylation of 3-substituted oxindoles via three-component Mannich reaction in aqueous media [J].TetrahedronLetters201(52): 903-906.
[5] Wen-Ting Wei, Ming-Bo Zhou, Jin-Heng Li,etal. Synthesis of Oxindoles by Iron-Catalyzed Oxidative 1,2-Alkylarylation of Activated Alkenes with an Aryl C(sp2)-H Bond and a C(sp3)-H Bond Adjacent to a Heteroatom [J].Angew.Chem.Int.Ed. 2013(52):3638-3641.
[6] Artur Pinto, Yanxing Jia, Jieping Zhu,etal.Palladium-Catalyzed Enantioselective Domino Heck-Cyanation Sequence:Development and Application to the Total Synthesis of Esermethole and Physostigmine [J].Chem.Eur.J. 2007(13):961-967.